Senate moves toward granting FDA greater regulatory oversight of supplements

Published



Senators advanced a controversial measure that would compel the Food and Drug Administration to play a greater role in regulating dietary supplements, a departure from agency custom that has rankled trade groups.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.